Xi Wang
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Electrospun Nanofibers in Biomedical Applications
- Molecular Medicine top 10%
- Hydrogels: synthesis, properties, applications
Papers in
- Biomaterials 21
- Nanoparticle-Based Drug Delivery 7
- Electrospun Nanofibers in Biomedical Applications 5
- Co-authors
- Fei Tian (10 shared papers)Jian Yang (8 shared papers)Kui Lin (7 shared papers)Zhaoyun Liu (6 shared papers)Qicong Shen (1 shared paper)Yangyang Chai (1 shared paper)Zhiqing Li (1 shared paper)Wenwen Huang (1 shared paper)
- Journals
- International Journal of Biological Macromolecules (7 papers)Journal of Colloid and Interface Science (3 papers)Frontiers in Immunology (2 papers)Journal of Food Composition and Analysis (2 papers)Pharmacological Research (2 papers)
- Partner nations
- ChinaUnited StatesIreland
In The Last Decade
Xi Wang
103 papers receiving 1.7k citations
Xi Wang's Hit Papers
Peers
Comparison fields: 5 of 138
- Biomaterials 237
- Molecular Medicine 69
- Immunology 238
- Biomedical Engineering 342
- Polymers and Plastics 105
Countries citing papers authored by Xi Wang
This map shows the geographic impact of Xi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Wang more than expected).
Fields of papers citing papers by Xi Wang
This network shows the impact of papers produced by Xi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Wang. The network helps show where Xi Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance Hit paper breakdown → | 2022 | 230 |
| 2 | 2022 | 105 | |
| 3 | 2007 | 70 | |
| 4 | 2023 | 68 | |
| 5 | 2017 | 44 | |
| 6 | 2018 | 43 | |
| 7 | 2006 | 37 | |
| 8 | 2017 | 35 | |
| 9 | 2015 | 34 | |
| 10 | 2022 | 34 | |
| 11 | 2023 | 34 | |
| 12 | 2015 | 32 | |
| 13 | 2023 | 32 | |
| 14 | 2023 | 31 | |
| 15 | 2014 | 30 | |
| 16 | 2016 | 29 | |
| 17 | 2022 | 29 | |
| 18 | 2009 | 29 | |
| 19 | 2023 | 27 | |
| 20 | 2023 | 25 |
About Xi Wang
Xi Wang is a scholar working on Biomaterials, Molecular Biology, Biomedical Engineering, Materials Chemistry and Organic Chemistry, having authored 112 papers that have together received 1.7k indexed citations. Recurring topics across this work include Immune cells in cancer (7 papers), Nanoparticle-Based Drug Delivery (7 papers), Antimicrobial agents and applications (5 papers), Advanced Polymer Synthesis and Characterization (5 papers), Electrospun Nanofibers in Biomedical Applications (5 papers), Polymer Surface Interaction Studies (5 papers), Dendrimers and Hyperbranched Polymers (5 papers) and Graphene and Nanomaterials Applications (5 papers). The work is most often cited by research in Biomaterials (237 citations), Molecular Medicine (69 citations), Immunology (238 citations), Biomedical Engineering (342 citations) and Polymers and Plastics (105 citations). Xi Wang has collaborated with scholars based in China, United States and Ireland. Frequent co-authors include Fei Tian, Jian Yang, Kui Lin, Jian Yang, Zhaoyun Liu, Qicong Shen, Yangyang Chai, Zhiqing Li, Wenwen Huang and Fangli Yuan. Their work appears in journals such as International Journal of Biological Macromolecules, Journal of Colloid and Interface Science, Frontiers in Immunology, Journal of Food Composition and Analysis and Pharmacological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.